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The activity of CDP-choline-dependent glycerophosphorylcholine synthetase (CDP-choline:sn-3-glycero- 
phosphate cholinetransferase), a newly discovered enzyme involved in the recently proposed pathways of 
acyl-specific phosphatidylcholine synthesis, is reported in rat liver. Endogenous CDP-choline, synthesized 
via the CMP-driven back reaction of phosphorylcholine transferase, is also shown to be a choline donor 
for this glycerophosphorylcholine synthetase. The function of glycerophosphorylcholine as an intermediate 
in phosphatidylcholine synthesis is demonstrated by specific isotope trapping whereby unlabelled glycero- 
phosphorylcholine inhibited label incorporation from sn-[Wlglycerol-3-phosphate into phosphatidylcho- 
line in mouse gastrocnemius, a tissue that is essentially devoid of the cytidine pathway for phosphatidylcho- 
line synthesis and uses a non-allelic glycerophosphorylcholine synthetase (exogenous PC:sn-3-glycerophos- 
phate cholinetransferase) in the synthesis of glycerophosphorylcholine. 
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1. INTRODUCTION 
New biosynthetic pathways for acyl-specific 
phospholipids have been postulated [ 11. In these 
new sequences, de novo synthesized glycerophos- 
phodiesters are proposed to be intermediates in the 
synthesis of acyl-specific PC, PE, PG, PI and PS. 
A GPC-dependent pathway of PC synthesis has 
also been proposed to operate in the synthesis of 
di-Cl6 : O-PC, the principal phospholipid compo- 
nent of lung surfactant, and in the synthesis of 
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highly unsaturated PC in other tissues, such as 
brain, muscle and spermatozoa [1,2]. Two non- 
allelic GPC synthetases have been postulated to oc- 
cur in various tissues [ 11. In tissues which have an 
active cytidine pathway for PC synthesis (such as 
liver, lung and brain) GPC has been proposed to 
be synthesized by the transfer of choline from 
CDP-choline to sn-glycerol-3-phosphate (CDP- 
choline : sn-glycerol-3-phosphate cholinetransfer- 
ase). In tissues such as fully differentiated skeletal 
muscle, in which the cytidine pathway for PC syn- 
thesis is essentially absent [3], exogenous PC has 
been proposed as a choline donor for sn-3-glycero- 
phosphate to form GPC (i.e. exogenous PC :sn- 
3-glycerophosphate cholinetransferase). Experi- 
mental evidence of de novo ‘GPC and GPE syn- 
thesis has been obtained in mouse brain, liver [3] 
and muscle [3,4]. In addition, evidence for a 
proposed primary defect in GPC synthetase in 
Duchenne and murine dy muscular dystrophies [5] 
has been obtained in the mouse [3,4]. 
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This paper reports for the first time de novo 
GPC synthesis via the CDP-choline : sn-glycerol- 
3-phosphate cholinetransferase, using rat liver, 
and the involvement of GPC as an intermediate in 
the synthesis of PC, in mouse gastrocnemius. 
2. MATERIALS AND METHODS 
2.1. Animals 
Adult male (3-4 months old) Sprague-Dawley 
rats were obtained from Blue Spruce Farms (Alta- 
mont, NY) as weanlings and fed Purina rat chow 
ad libitum until use. Adult male (2-3 months old) 
C3H/HeN mice were obtained from a breeding 
colony originating from the National Institutes of 
Health. The Center for Research Animal 
resources’ guide for the care and use of laboratory 
animals of Cornell University was followed. 
2.2. Chemicals 
ATP, UTP, CMP, CDP-choline, L-carnitine, 
CoA-SH, DL-cu-tocopherol, palmitoyl-CoA, and 
all-cis-4,7,10,13,16,19-docosahexaenoic ac d were 
obtained from Sigma (St. Louis, MO). MgClz 
(1.0 M solution) was obtained from Fisher Scien- 
tific (Fair Lawn, NJ). [U-‘4C]Glycerol-3-phos- 
phate (140 mCi/mmol) and cytidine-5 ’-diphos- 
pho[Me-‘4C]choline (49 mCi/mmol) were ob- 
tained from New England Nuclear (Boston, MA). 
All common chemicals were of reagent grade or of 
the highest purity available. 
2.3. Homogenate preparation 
Animals were killed by cervical dislocation; 
livers and muscle were immediately excised, blot- 
ted and homogenized in 5 vols of ice-cold 0.25 M 
sucrose. Post-nuclear and connective tissue-free 
supernatants were obtained by centrifugation at 
600 x g for 10 min, at 4’C. 
2.4. Enzyme assays 
The complete assay medium for incorporation 
of sn-[‘4C]glycerol-3-phosphate into GPC con- 
tained: 0.54 mM sn-[U-14C]glycerol-3-phosphate 
(2.6 mCi/mmol), 3.0 mM MgUTP’-, 1.0 mM 
CDP-choline, 2.3 mM free Mg2+ and 80 mM 
Hepes, pH 7.0, with 3.1-3.5 mg of homogenate 
protein. In assay protocols where CMP substituted 
for CDP-choline, the substitution was equimolar. 
The complete assay medium for CDP-[‘4C]choline 
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incorporation into GPC was identical to that in- 
dicated above for sn-[‘4C]glycerol-3-phosphate in-
corporation except that unlabeled sn-glycerol-3- 
phosphate replaced its labeled counterpart and 
CDP-[Me-14C]choline (3.8 mCi/mmol) replaced 
its unlabeled counterpart. Initial velocities were 
obtained with 15-30 min incubations at 37°C. 
Reaction rates were first order with respect o pro- 
tein concentrations at the above protein levels, 
Other assay procedures have been described [3,4]. 
Incorporation of sn-[14C]glycerol-3-phosphate into 
PC and PE was assayed in a medium containing: 
0.54 mM [U-14C]glycerol-3-phosphate (2.6 mCi/ 
mmol), 2.3 mM free Mg2+, 3.0 mM MgUTP2-, 
1.3 mM L-carnitine, 0.030 mM DL-cY-tocopherol, 
0.040 mM C22 : 6n-3, 0.030 mM palmitoyl-CoA, 
0.40 mM CoASH, 80 mM Hepes, pH 7.0 and 
1.3-l .7 mg homogenate protein; assay media were 
sonicated before addition of homogenate. Some 
assay protocols included 1 .O mM GPC or CDP- 
choline. Incubations were at 37°C for 30 min. 
Reactions were stopped with 1.1 ml of 2: 1 (v/v) 
chloroform-methanol containing 0.05% (w/v) 
butylated hydroxytoluene: phospholipids were 
subsequently extracted in the lower phase of the 
resulting Folch [6] solvent system. All assays were 
carried out in a volume of 0.375 ml. MgUTP’- 
was included in the assay protocols as an alter- 
native substrate for competing endogenous 
nucleotidases (EC 3.1.3.5) and other phosphoryl- 
hydrolases; these hydrolytic activities have pre- 
viously been detected in muscle and other tissues 
[3,11,12]. 
2.5. Analytical 
GP and GPC were resolved by ion-exchange 
paper chromatography as previously described [4]. 
The same system was used to resolve CDP-choline, 
GPC and choline: Rf values were 0.30, 0.58 and 
0.85, respectively. Identification of choline and the 
various phosphoryl-substituted compounds has 
been described [3]. PC and PE were resolved by 
silica gel TLC [7]; spots were scraped for radioac- 
tivity determination. Radioactivity was measured 
by liquid scintillation spectrometry as described 
before [3]. 
2.6. Miscellaneous 
Concentrations of various ligands and Mg 
species were calculated from solutions of the cor- 
Volume 214, number 1 FEBS LETTERS April 1987 
responding multiple equilibria equations as in- 
dicated before [4]. Protein was determined by the 
Folin phenol reagent [8] with crystalline bovine 
serum albumin as a standard. Statistical analysis 
was performed with a computerized version 
(MINITAB, Statistics Dept, Pennsylvania State 
University) of the t-test [9] and analysis of variance 
HOI. 
3. RESULTS AND DISCUSSION 
The requirements for GPC synthesis in liver as 
measured by the sn-[14C]glycerol-3-phosphate 
assay are shown in table 1. The enzyme shows a 
strong dependence on exogenous CDP-choline, 
since in its absence the rate of GPC synthesis is 
about half that of the complete assay. However, 
the sizable activity without an exogenous choline 
donor suggests that the homogenate has a signifi- 
cant concentration of CDP-choline or that it can 
be generated from endogenous ources. The obser- 
vation that CMP can substitute for CDP-choline is 
consistent with the proposed role of the reverse 
reaction of the CDP-choline : 1 ,Zdiacylglycerol 
cholinephosphotransferase (EC 2.7.8.2) in supply- 
ing CDP-choline for the GPC-dependent pathway 
of PC synthesis [l]. This reaction, operating with 
endogenous PC and CMP, may account for the 
substantial rate of GPC synthesis in the absence of 
Table 1 
CDP-choline : sn-glycerol-3-phosphate cholinetransfer- 
ase activity in rat liver 
Labeled substrate nmol GPC/mg 
protein 
per mina 
Complete sn-[14C]glycerol-3-phosphate 
assay 0.352 f 0.025 
- CDP-choline 0.185 f 0.027 
- CDP-choline, + CMP 0.301 * 0.020 
Complete CDP-[‘4C]choline assay 0.263 f 0.018 
_ sn-glycerol-3-phosphate 0.031 f 0.005 
a Significant differences: 0.352 > 0.185 at P < 0.0001; 
0.301 > 0.185 at P = 0.0003; 0.352 > 0.301 at P = 0.02; 
0.263 > 0.031 at P < 0.0001; 0.352 > 0.263 at P = 
0.0013 
Assay conditions as indicated in section 2 (n = 4) 
exogenous CDP-choline as observed above. At the 
same time, the increased synthesis of GPC by 
CMP (with respect to the rate in the absence of 
CDP-choline) rules out the possibility that GPC 
was being made from PC synthesized by the 
cytidine pathway, since CMP as a product of the 
last step of this pathway (i.e. catalyzed by the 
phosphorylcholine transferase) would inhibit the 
synthesis of PC via this pathway, as observed by 
others [13,14]. The direct synthesis of GPC from 
CDP-choline and G3P is also substantiated by the 
observed initial velocity condition in these assays; 
otherwise, a catabolic origin of GPC would pro- 
duce a long lag period in the appearance of label 
in GPC, since there are six intermediate steps be- 
tween G3P and GPC if this glycerophosphodiester 
was being synthesized via the cytidine pathway 
followed by PC catabolism. 
The rate of GPC synthesis as measured by the 
CDP-[r4C]choline incorporation assay is also in- 
dicated in table 1. This biosynthetic rate is 
somewhat less than from sn-[14C]glycerol-3- 
phosphate, i.e. 0.263 vs 0.352 units. Since the com- 
plete assay protocols provided identical reactant 
concentrations for both radioassays, observed 
reaction rates would be expected to be similar ac- 
cording to the postulated stoichiometry [l]. How- 
ever, this deviation from the predicted stoichio- 
metry in this crude homogenate is expected if there 
is substantial endogenous synthesis of CDP- 
choline, which would lead to label dilution; that 
this is the case is shown by the only partial require- 
ment for exogenous CDP-choline in the synthesis 
of GPC from labeled G3P (table 1). Purification 
of this CDP-choline-dependent GPC synthetase 
will be required to confirm the expected stoichio- 
metry. The strong dependence of GPC synthesis 
on exogenous G3P is consistent with the previously 
proposed reaction scheme [l]. However, the 
residual activity without exogenous G3P suggests 
that the homogenate contains a small but de- 
tectable endogenous G3P concentration. 
The experiment for which data are shown in 
table 2 was designed to test the previous proposi- 
tion that GPC is indeed an intermediate in the syn- 
thesis of PC [ 11. The entry of labeled G3P into PC 
via the classic cytidine pathway should be preclud- 
ed in this experiment since fully differentiated 
mouse skeletal muscle is essentially devoid of the 
enzymes of this cytidine pathway [3,4]. These data 
151 
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show that sn-[14C]glycerol-3-phosphate is incor- 
porated into muscle PC and PE in an assay 
medium containing acyl donors. Addition of ex- 
ogenous unlabeled GPC produced a significant 
and specific inhibition (73%) of label incorpora- 
tion into PC, whereas label incorporation into PE 
remained unchanged. These data indicate that 
GPC acts as a specific isotope trap for labeled G3P 
incorporation into PC, suggesting that GPC is a 
required intermediate in the synthesis of PC from 
G3P in this tissue. The lack of inhibition of labeled 
G3P incorporation into PE precludes the effect of 
GPC as a source of unlabeled G3P via a residual 
phosphodiesterase activity. To confirm the func- 
tional absence of the cytidine pathway for PC syn- 
thesis, the same experiment was repeated with the 
addition of 1 .O mM CDP-choline. The presence of 
CDP-choline did not increase the rate of PC syn- 
thesis from labeled G3P when muscle homogenates 
were used for this assay (table 2). These data con- 
firm the previous conclusion that skeletal muscle 
PC is not synthesized via the cytidine pathway in 
the mouse [3,4], and shows that G3P is a common 
substrate for both the cytidine and glycerophos- 
phodiester-dependent pathways of phospholipid 
synthesis. 
The proposed CDP-choline-dependent synthesis 
of PC [l], via a pathway not involving the forward 
reaction of the phosphorylcholine transferase of 
the classic cytidine pathway, offers an alternative 
mechanism for the lack of coupling of CDP- 
choline and diacylglycerol incorporation into PC 
observed in liver and other tissues [ 15-191, other 
than the suggested compartmentalization of 
Table 2 
Incorporation of sn-[i4C]glycerol-3-phosphate into 
mouse gastrocnemius PC and PE, in the presence or 
absence of GPC or CDP-choline 
Reactants PCs PE 
- GPC 0.088 f 0.007 0.021 f 0.004 
+ GPC 0.023 f 0.004 0.020 f 0.004 
+ CDP-choline 0.084 f 0.009 0.023 f 0.004 
a Significant differences: 0.088 > 0.023 at P < 0.0001; 
0.084 not significantly different from 0.088 at P = 0.10 
Data in nmol phospholipid/mg protein per min (n = 4). 
Assay conditions as indicated in section 2 
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diacylglycerol pools. A high rate of de novo GPC 
synthesis has been reported in these tissues [3,20], 
which is consistent with the operation of GPC- 
dependent PC synthesis. 
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